Safety Study of Rufinamide Given as an add-on Therapy to Treat Patients With Seizures

NCT04558580 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Refractory Partial Seizures

Interventions

DRUG: Rufinamide

Sponsor

University of South Alabama